Targeted radiation blast tested in fight against liver cancer
NCT ID NCT07334483
Summary
This study is testing a combination of treatments for liver cancer that cannot be removed by surgery. It compares a targeted radiation injection, given alone or with two other drugs (an immunotherapy and a targeted therapy), against the current standard procedure (chemoembolization). The goal is to see which approach is better at controlling the cancer and is safer for patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tsinghua Changgung Hospital
RECRUITINGBeijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Nanjing Tianyinshan Hospital
NOT_YET_RECRUITINGNanjin, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Zhongshan Hospital Fudan University
RECRUITINGShanghai, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.